Credit Suisse analyst Susan Maklari maintained a Buy rating on DR Horton (DHI) yesterday and set a price target of $46. The company’s shares closed yesterday at $39.60.
According to TipRanks.com, Maklari ‘s ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -6.1% and a 44.6% success rate. Maklari covers the Consumer Goods sector, focusing on stocks such as Skyline Champion Corporation, Stanley Black & Decker Inc, and Green Brick Partners.
DR Horton has an analyst consensus of Moderate Buy, with a price target consensus of $43.38, representing a 9.5% upside. In a report issued on January 9, KBW also upgraded the stock to Buy with a $45 price target.
.
See today’s analyst top recommended stocks >>
DR Horton’s market cap is currently $14.9B and has a P/E ratio of 10.43. The company has a Price to Book ratio of 1.66.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
D.R. Horton, Inc. operates as a national homebuilder that engages in the construction and sale of single-family housing. It operates through the Homebuilding and Financial Services segments. The Homebuilding segment includes the sub-segments East, Midwest, Southeast, South Central, Southwest, and West regions.
